Felix NeuroAI™ Wristband
The world’s first AI therapeutic for essential tremor has been cleared by the U.S. FDA
Felix is a recent breakthrough in neurotechnology and artificial intelligence. It’s a 100% noninvasive, easy-to-use alternative to surgery and medication – delivering all-day relief for individuals living with essential tremor.
About Fasikl
Creating Groundbreaking AI Therapeutics
Building on over 20 years of intensive R&D, Fasikl has pioneered advanced AI technologies to decode and modulate neural signals, establishing a groundbreaking foundation for AI therapeutics. Our innovative platform enables cloud-based AI to collaborate with the brain, managing diseases in entirely new ways.
Fasikl AI doesn’t just communicate – it treats.
Patient-First Spirit
Fasikl works for patients. We seek to understand the challenges faced by patients and their families and strive to develop better therapies that meaningfully improve quality of life. This patient-first spirit is built into every stage of what we do – from research and clinical development to business decisions, manufacturing, and patient service. We continuously refine how we work to serve each patient in the most thoughtful and practical way possible.
If science is divine, it should heal.
We believe in the power of science and technology to create better therapies, improve healthcare, and make a meaningful difference in people’s lives.
Research Innovation
- Ultra-low-noise neural recording technologies enable high-precision measurement of signals from the human nervous system.
- Bidirectional neural interfaces enable near-simultaneous neural recording and stimulation, creating opportunities to capture neural data during therapy and refine AI models.
- Human-AI co-adaptation allows biological and artificial intelligence to work together, providing the foundation for a new generation of AI therapeutics.
Manufacturing & Service
- In-house manufacturing and production lines provide close control over every step, so each Felix device is carefully crafted and inspected.
- Rigorous quality, inspection, and maintenance processes are supported by an FDA-registered, ISO 13485-certified manufacturing infrastructure.
- A hybrid human-AI service model combines AI efficiency with human judgment and care to provide high-quality, transparent, scalable, and compliant patient support.
Clinical Evidence
- A randomized, double-blind, sham-controlled, multi-regional clinical trial demonstrated superiority to sham treatment and met its primary endpoint.
- Longer-term studies demonstrate progressive and sustained improvement, with benefits that are both statistically significant and clinically meaningful.
- Real-world patient experiences and feedback help us understand individual needs and continuously improve the treatment experience.
Access & Billing
- An online patient portal makes the process of accessing Felix straightforward and transparent.
- Comprehensive patient support extends from benefit verification and device fitting through delivery and ongoing service.
- A growing insurance network, alongside Medicare and VA coverage, helps make Felix accessible to more eligible patients.
